C. Blaser et al., Cytos Biotechnology AG - Novel technologies for functional genomics and antibody mediated therapies, CHIMIA, 54(4), 2000, pp. 165-168
The overall goal of Cytos is the creation of new technologies and products
for broad markets by breakthrough innovations in the biomedical sciences. B
y adding eukaryotic viruses to the toolbox of modern biotechnology, Cytos h
as developed unprecedented and broadly applicable platform technologies for
drug discovery and development. Our technologies enable and facilitate the
discovery, manufacture, delivery, and display of proteins.